Latest Corporate News
Olympus launches $150M second venture fund to boost MedTech innovation
Olympus announced a $150 million commitment to Olympus Innovation Ventures Fund II targeting GI, urology and respiratory MedTech startups to generate M&A and partnership opportunities and provide clinical and go-to-market support for portfolio companies; Cerity Partners Ventures will continue to help manage the fund.
Alexander & Baldwin to be taken private in $2.3B deal led by Blackstone and partners
Alexander & Baldwin entered a definitive merger agreement to go private for $21.20 per share in an all-cash transaction with MW Group, Blackstone Real Estate and DivcoWest; the board unanimously approved the $2.3 billion enterprise-value deal, expected to close in Q1 2026 subject to customary conditions.
Cencora accelerates acquisition of OneOncology to broaden oncology services
Cencora announced a definitive agreement to acquire the remaining equity in OneOncology from TPG to expand its management services and community oncology solutions, advancing its integrated care offerings for oncology providers and patients.
UKG to acquire Inova Payroll to expand SMB HR/payroll offerings
UKG entered into a definitive agreement to buy Inova Payroll, aiming to provide outsourced HR, payroll and benefits-brokerage services to small and mid-sized businesses and extend UKG’s workforce-management platform into the SMB market.
Einride confidentially files Form F-4 ahead of SPAC business combination
Electric and autonomous freight operator Einride and Legato Merger Corp. III filed a draft Form F-4 with the SEC for their proposed business combination, which could deliver roughly $220 million in gross proceeds and aims for an NYSE listing upon closing expected in H1 2026.
Relief Therapeutics and NeuroX complete business combination to form MindMaze Therapeutics
The business combination closed to form MindMaze Therapeutics, a Swiss commercial-stage company integrating digital neurotherapeutics, pharmacology, devices, data and an AI platform to target neurological care innovation following shareholder approvals and prior agreements.
Major M&A trend: record dealmaking with Middle East capital and activist/hostile bids shaping outcomes
Dealmakers are navigating a high-value M&A wave—fuelled by Middle East capital, big strategic checks and activist/hostile approaches—creating a $100 billion year-end cliffhanger and reshaping corporate strategy across sectors according to Bloomberg coverage of 2025 deal activity.